Bristol-Myers Squibb appoints Mike Burgess M.D., Ph.D. Senior Vice President, Discovery Medicine and Clinical Pharmacology
17 January 2013 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb appoints Mike Burgess...
List view / Grid view
News
Boehringer Ingelheim enrols first patients in pivotal Phase III interferon-free hepatitis C trial programme
17 January 2013 | By Boehringer Ingelheim
"Diabetes affects more than 371m people..."
Vifor Pharma and China Medical System Holdings Limited sign distribution agreement
17 January 2013 | By Thomson Reuters
Vifor Pharma has entered into an exclusive distribution agreement with CMS...
Vestiq Pharmaceuticals, Inc. launches with agenda for rapid growth, acquires NDAs for ORAVIG® and Zuplenz® oral soluble film
16 January 2013 | By WHITECOAT Strategies, LLC
Vestiq announces its launch of products...
Lonza and BaroFold announce a technology evaluation agreement for PreEMT™
Lonza, a leader in biological development and BaroFold, Inc., an innovative protein technology developer, announced today a non-exclusive technology and license agreement whereby Lonza will evaluate BaroFold’s PreEMT™ high pressure refolding technology for use in biological development refolding processes.
European Commission approves PREZISTA® (darunavir) 800mg tablet once a day
16 January 2013 | By prnewswire.co.uk
The European Commission has approved a new PREZISTA® (darunavir) 800mg tablet...
Amgen announces top-line results of Phase 3 Aranesp® (darbepoetin alfa) RED-HF® trial
16 January 2013 | By Amgen
Amgen announced top-line results of the Phase 3 Aranesp® RED-HF® Trial...
Daiichi Sankyo and Ranbaxy to leverage synergies in Thailand
16 January 2013 | By Daiichi Sankyo
Daiichi Sankyo and Ranbaxy announced their intention to integrate their business operations in Thailand...
Biogen Idec and Elan submit applications for first-line use of TYSABRI in anti-JCV antibody negative patients with MS
16 January 2013 | By Biogen Idec
Biogen Idec and Elan have submitted applications to the U.S. FDA...
U.S. FDA grants priority review to Boehringer Ingelheim’s Afatinib* NDA for EGFR mutation-positive advanced NSCLC
16 January 2013 | By Boehringer Ingelheim
The acceptance of the NDA filing reinforces our ongoing commitment to oncology..."
Amgen to build state-of-the-art manufacturing facility in Singapore
16 January 2013 | By Amgen
Amgen announced plans to build a new manufacturing facility in the Tuas Biomedical Park area of Singapore...
AstraZeneca announces changes to Senior Executive Team
15 January 2013 | By AstraZeneca
AstraZeneca unveiled changes to its executive leadership team...
Daiichi Sankyo and ArQule announce top-line results of Phase 2 trial with tivantinib in colorectal cancer
15 January 2013 | By Daiichi Sankyo
“We are encouraged by these findings..."
Change to the Roche Corporate Executive Committee
15 January 2013 | By Roche
John C. Reed, M.D., Ph.D., has been appointed Head of Roche pRED and member of the enlarged Corporate Executive Committee...
New 1.3-micron Kinetex core-shell media delivers superior UHPLC performance
15 January 2013 | By Phenomenex
“The Kinetex product line spans our customers’ needs..."
